Jason Slakter, MD, an ophthalmologist at Vitreous Retina Macula Consultants of New York in New York City, has become the first physician to administer Syfovre, a treatment for geographic atrophy in ...

A ranibizumab implant (Port Delivery System) could ease treatment burden, and even improve long-term visual acuity, in people with neovascular age-related macular degeneration, interim results from ...

According to the National Eye Institute, age-related macular degeneration impacts 11 million adults in the U.S. every year. Characterized by a loss of the vision needed to see straight ahead and by ...

The treatment for cataracts, a pharmaceutical implant, is inserted into the vitreous of the eye using a precision delivery system following a vitrectomy, eye surgery that removes the vitreous to reach ...

TARRYTOWN, N.Y. -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that EYLEA ® (aflibercept) Injection has received approval for the treatment of patients with neovascular age-related macular ...

Approval based on the pivotal PULSAR and PHOTON trials in which EYLEA® HD demonstrated clinically equivalent vision gains to EYLEA (aflibercept) Injection 2 mg that were maintained with fewer ...

Fact checked by Nick Blackmer Dark spots or squiggles drifting across your field of vision are called floaters.Floaters are more common as you age, when a substance called vitreous gel begins ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

In April 2017, in Washington, DC, AJMC® Peer Exchange® hosted a panel of ophthalmology and managed care decision makers and providers to define age-related macular degeneration (AMD) and to provide ...

A 46-year-old Caucasian man presented with vague abdominal symptoms, constipation, and painless loss of vision bilaterally. The presenting visual acuity was 6/36 in the right eye and hand movements in ...

VANCOUVER, Canada — An experimental implant that delivers ranibizumab controls the progression of neovascular age-related macular degeneration as well as injections, results from the phase 2 LADDER ...

Age-related macular degeneration (AMD) causes significant vision loss in seniors who have it. And there are many of them. This degenerative eye disease affects more than 500,000 Quebecers, about five ...